Pharma

Chinese drug maker Fosun to buy Gland Pharma for $1.5 bn

“The pharma, healthcare and biotech sector has seen high levels of activity in the M&A space during 2015. The transaction volumes have been the highest in the last five years. In 2015, 65 M&A transactions valued at $4.04 billion were executed as against 64 transactions valued at $5.7 billion in 2014.”

Annual Deal Tracker 2015
Grant Thornton Advisory Private Limited

 

This article apeared in Live Mint on 28th July, 2016.